July 17, 2019
AUM Biosciences Expands Pipeline With Global License for First-in-class Targeted Cancer Therapy
Second major acquisition sets Singapore headquartered company on course to uniquely drive global therapeutic innovation from Asia SINGAPORE–(BUSINESS WIRE)–AUM Biosciences…